Background. The rate of inpatient mastectomies remains high despite multiple studies reporting favourably on outpatient mastectomies. Outpatient mastectomies do not compromise quality of patient care and are more efficient than inpatient care. The objective of this study was to evaluate the feasibility of outpatient mastectomy. Materials and Methods. Implementation of an outpatient mastectomy program was evaluated in a retrospective study. All patients who underwent mastectomy between January 2019 and September 2021 were included. Results. 213 patients were enrolled in the study: 62.4% (n = 133) outpatient mastectomies versus 37.6% (n = 80) inpatient mastectomies. A steady rise in outpatient mastectomies was observed over time. The second quarter of 2020, coinciding with the first COVID-19 wave, showed a peak in outpatient mastectomies. The only significant barrier to outpatient mastectomy proved to be bilateral mastectomy. Unplanned return to care was observed in 27.8% of the outpatient versus 36.3% of the inpatient mastectomies (); the reason for unplanned return of care was similar in both groups. Conclusions. Outpatient mastectomy is shown to be feasible and safe with a steady increase during the study period. A barrier to outpatient mastectomy was bilateral mastectomy. Incidence of unplanned return to care or complications did not differ significantly between the outpatient and inpatient cohorts.

中文翻译：

---

COVID-19 时代对门诊乳房切除术的探索：障碍和促进因素

背景。尽管多项研究报告了门诊乳房切除术，但住院乳房切除术的发生率仍然很高。门诊乳房切除术不会影响患者护理的质量，并且比住院护理更有效。本研究的目的是评估门诊乳房切除术的可行性。材料和方法。一项回顾性研究评估了门诊乳房切除术的实施情况。纳入了 2019 年 1 月至 2021 年 9 月期间接受乳房切除术的所有患者。结果。213 名患者参加了研究：62.4% ( n  = 133) 门诊乳房切除术对 37.6% ( n = 80) 住院乳房切除术。随着时间的推移，观察到门诊乳房切除术的人数稳步上升。2020 年第二季度，恰逢第一波 COVID-19 浪潮，门诊乳房切除术出现高峰。门诊乳房切除术的唯一重大障碍被证明是双侧乳房切除术。在 27.8% 的门诊患者和 36.3% 的住院患者乳房切除术中观察到计划外返回护理（); 两组意外返回护理的原因相似。结论。门诊乳房切除术被证明是可行和安全的，并且在研究期间稳步增加。门诊乳房切除术的一个障碍是双侧乳房切除术。门诊患者和住院患者的计划外返回护理或并发症的发生率没有显着差异。